JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Aβ

B6057 Amyloid β-Peptide (1-42) (human)
2 Citation

insoluble in H2O; insoluble in EtOH; ≥40.5 mg/mL
A1038 Amyloid β-Peptide (10-20) (human)

Summary: Initiates neurodegeneration in Alzheimer disease

insoluble in EtOH; ≥144.7 mg/mL
A1039 Amyloid Beta-peptide (25-35) (human)
1 Citation

Summary: Functional domain of Aβ

insoluble in EtOH; insoluble in H2O; ≥106 mg/mL
A1123 Amyloid Beta-Peptide (12-28) (human)

Summary: sequence H2N-VHHQKLVFFAEDVGSNK-OH

≥195.5 mg/mL
A1124 Amyloid Beta-Peptide (1-40) (human)
1 Citation

Summary: Amyloid precursor protein

insoluble in EtOH; ≥23.8 mg/mL
A1002 Beta-Amyloid (1-11)

Summary: Amyloidogenic peptide

insoluble in EtOH; ≥132.5 mg/mL
A1003 Amyloid β-Protein (1-15)

Summary: Principal component of amyloid

insoluble in EtOH; ≥182.6 mg/mL
A1004 Amyloid Precursor C-Terminal Peptide

Summary: For beta amyloid generation

≥189.6 mg/mL
A1005 Beta-Sheet Breaker Peptide iAβ5

Summary: Peptide which can inhibit amyloidogenesis

≥63.7 mg/mL
A1026 β-Interleukin I (163-171), human

Summary: T cell activator

insoluble in EtOH; ≥100.4 mg/mL